Soleno Therapeutics, Inc. logo SLNO - Soleno Therapeutics, Inc.

Inactive Ticker SLNO is not actively trading. Quotes and analytics may be stale.
Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 8
HOLD 5
SELL 0
STRONG
SELL
0
| PRICE TARGET: $76.50 DETAILS
HIGH: $100.00
LOW: $53.00
MEDIAN: $76.50
CONSENSUS: $76.50
UPSIDE: 44.31%
AlphaQuality

AlphaQuality

Quantitative six-pillar business-quality grade

High-Growth Software

AlphaQuality — archetype-weighted quantitative grade

F 29.5 / 100 pillar composite

Composite Grade

Composite of six pillars weighted for high-growth software businesses. Purely quantitative — the six pillars score only reported financials, no analyst input.

⚠ 4 of the last 5 fiscal years showed negative net income — AlphaQuality will not grade above F for persistent unprofitability in a high-growth software business.

Grade overrides the 29.5 pillar composite because hard gates always win. Use the pillar breakdown below to see where the underlying numbers sit.

Profitability

Weight: 15%
F 0.0
  • 5yr Avg ROIC -76.4% 0/100
Contributes 0.0 pts toward composite.

Capital Efficiency

Weight: 15%
F 0.0
  • 5yr Avg ROE -99.6% 0/100
  • 5yr Share-Count CAGR 67.1% 0/100
Contributes 0.0 pts toward composite.

Growth Quality

Weight: 35%
F 0.0
  • Revenue-Growth Years (5) 0/5 0/100
Contributes 0.0 pts toward composite.

Cash Generation

Weight: 20%
A- 86.4
  • 5yr FCF Margin 24.5% 95/100
  • 5yr FCF/NI Conversion 2.24x 76/100
Contributes 17.3 pts toward composite.

Balance Sheet

Weight: 10%
A 88.9
  • Net Debt / EBITDA -10.67x 100/100
  • Interest Coverage (EBIT/Int) 4.81x 63/100
  • Altman Z-Score 14.63 100/100
Contributes 8.9 pts toward composite.

Stability

Weight: 5%
B- 66.7
  • Piotroski F-Score 6 67/100
Contributes 3.3 pts toward composite.

Guru Flow

Curated superinvestor sentiment — not part of the AlphaQuality grade.
Dumping

0 of 2 gurus held; 2 full exits.

Holders
0 -2
Avg Δ position
New buys
0
Full exits
2
As of Q2 2026
How this is calculated

AlphaQuality grades six pillars from 0-100 and weights each by archetype:

  • Profitability (15%) — 5yr Avg ROIC
  • Capital Efficiency (15%) — 5yr Avg ROE, 5yr Share-Count CAGR
  • Growth Quality (35%) — Revenue-Growth Years (5)
  • Cash Generation (20%) — 5yr FCF Margin, 5yr FCF/NI Conversion
  • Balance Sheet (10%) — Net Debt / EBITDA, Interest Coverage (EBIT/Int), Altman Z-Score
  • Stability (5%) — Piotroski F-Score

The six pillars read only reported financial-statement fields — no analyst targets or consensus ratings. The archetype that picks which pillar formulas apply is not fully price-free, though: it can route a company to the distressed/ungradable archetype based on price vs. its 52-week high, and beta affects one classification check. A minimum of 5 fiscal years of audited statements is required. Insurers and banks are graded on their own methodology — insurers on loss ratio, its trend and stability, and premiums-to-surplus; banks on the efficiency ratio, its trend and stability, and equity-to-assets — rather than on industrial margin/ROIC signals. Distressed, highly leveraged infrastructure, asset-manager, and other financial businesses are declared ungradable rather than forced into a numeric score.